Occupational and environmental risk factors for Parkinson's disease

Parkinsonism and Related Disorders

Volumn 8, Issue 5, 2002, Pages 297-309

  Lai, B C L ^a   Marion, S A ^a   Teschke, K ^a   Tsui, J K C ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Dietary factors; Environmental risk factors; Head injury; Infectious diseases; Lifestyle; Metals; Neurotoxins; Occupational risk factors; Parkinson's disease; Pesticides; Smoking

Indexed keywords

ALUMINUM; AMALGAM; ANTIOXIDANT; COPPER; IRON; LEAD; MANGANESE; MERCURY; METAL; PESTICIDE; ZINC;

DIET; DIETARY INTAKE; DISEASE COURSE; ENVIRONMENT; ENVIRONMENTAL EXPOSURE; HEAD INJURY; HUMAN; INFECTION; INFLUENZA; LIFESTYLE; NONHUMAN; OCCUPATIONAL HAZARD; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; RURAL AREA; SMOKING; VIRUS INFECTION;

ENVIRONMENTAL EXPOSURE; HUMANS; OCCUPATIONAL EXPOSURE; PARKINSON DISEASE; RISK FACTORS;

EID: 0036091142     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1353-8020(01)00054-2     Document Type: Review

References (149)

1. Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976-1990
2. Parkinson's disease and parkinsonism in a longitudinal study: Two-fold higher incidence in men
3. Cross sectional prevalence survey of idiopathic Parkinson's disease and parkinsonism in London
4. Etiology of Parkinson's disease
5. Parkinson's disease. A clinical study of one hundred and forty-six cases
6. Cohort analysis of Parkinson's disease: Evidence for a single etiology related to subclinical infection about 1920
7. Chronic parkinsonism secondary to intravenous injection of meperidine analogues
8. Chronic parkinsonism in humans due to a product of meperidine-analog synthesis
9. Aetiology of Parkinson's disease
10. Kindreds of dominantly inherited Parkinson's disease: Keys to the riddle
11. Parkinson's disease: A test of the multifactorial etiologic hypothesis
12. Xenogenetics in multifactorial disease susceptibility
13. Environmental, medical, and family history risk factors for Parkinson's disease: A New England-based case control study
14. Familial aggregation of Parkinson's disease: A population-based case-control study in Europe. EUROPARKINSON Study Group
15. Epidemiology and genetics of Parkinson's disease
16. The genetics of Parkinson's disease
17. Parkinson disease in twins: An etiologic study
18. Worldwide occurrence of Parkinson's disease: An updated review
19. Parkinson's disease in populations of African origin: A review
20. Epidemiologic approaches to the study of Parkinson's disease etiology
21. Epidemiologic study of Parkinson's disease in Hong Kong
22. Environmental factors and Parkinson's disease: A case-control study in China
23. Parkinson's disease: A case-control study of occupational and environmental risk factors
24. Environmental risk factors in Parkinson's disease
25. Follow-up study of early-life protective and risk factors in Parkinson's disease
26. Facteurs environnementaux dans l'etiologie de la maladie de Parkinson
27. The epidemiology of Parkinson's disease. A case-control study of young-onset and old-onset patients
28. A pilot study of occupational and environmental risk factors for Parkinson's disease
29. Environmental risk factors in siblings with Parkinson's disease
30. Parkinson's disease and exposure to agricultural work and pesticide chemicals
31. Exposure to well water and pesticides in Parkinson's disease: A case-control study in the Madrid area
32. Environmental antecedents of young-onset Parkinson's disease
33. Risk factors for Parkinson's disease
34. A case-control study of Parkinson's disease in a horticultural region of British Columbia
35. Risk-factors for Parkinson's disease: Case-control study in the province of Caceres, Spain
36. Environmental exposures in elderly Canadians with Parkinson's disease
37. Possible environmental, occupational, and other etiologic factors for Parkinson's disease: A case-control study in Germany
38. Environmental risk factors and Parkinson's disease: A case-control study in Taiwan
39. Genetic and environmental risk factors for Parkinson's disease in a Chinese population
40. The risk of Parkinson's disease with exposure to pesticides, farming, well water, and rural living
41. Parkinson's disease
42. The epidemiology of Parkinson's disease in an Australian population
43. Nutritional and occupational factors influencing the risk of Parkinson's disease: A case-control study in southeastern Sweden
44. A case-control study of occupational and environmental risk factors for Parkinson's disease in the Emilia-Romagna region of Italy
45. Environmental risk factors in Parkinson's disease
46. Genetics, drugs and environmental factors in Parkinson's disease. A case-control study
47. Parkinson's disease and environmental factors
48. A meta-analysis of Parkinson's disease and exposure to pesticides
49. Parkinson's disease mortality and pesticide exposure in California 1984-1994
50. Effect of chlordane on hepatic mitochondrial respiration
51. Effect of heptachlor on hepatic mitochondrial oxidative phosphorylation in rat
52. Non-cholinergic toxicity of organophosphates in mammals: Interaction of ethaphos with mitochondrial function
53. Mitochondrial bioenergetics as affected by DDT
54. The pyrethroids permethrin and cyhalothrin are potent inhibitors of the mitochondrial complex I
55. Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenylpyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
56. Mitochondrial dysfunction in Parkinson's disease
57. Pesticides: An important but under used model for the environmental health sciences
58. Biotransformation of parathion in human liver: Participation of CYP3A4 and its inactivation during microsomal parathion oxidation
59. The effects of the phosphorothioate insecticide fenitrothion on mammalian cytochrome P450-dependent metabolism of estradiol
60. The effect of tridiphane (2-(3,5-dichlorophenyl)-2-(2,2,2-trichloroethyl)oxirane) on hepatic epoxide-metabolizing enzymes: Indications of peroxisome proliferation
61. Interaction of glutathione transferase Pl-1 with captan and captofol
62. Potentiated and preferential effects of combined paraquat and maneb on nigrostriatal dopamine systems: Environmental risk factors for Parkinson's disease?
63. Organochlorine insecticides in substantia nigra in Parkinson's disease
64. Chronic systemic pesticide exposure reproduces features of Parkinson's disease
65. Parkinson's disease and exposure to rural environmental factors: A population based case-control study
66. Environmental and genetic risk factors in Parkinson's disease: A case-control study in southern Italy
67. Health impact of organics in ground water
68. Epidemiologic study on the association between body burden mercury level and idiopathic Parkinson's disease
69. Occupational exposures to metals as risk factors for Parkinson's disease
70. Occupational exposure to manganese, copper, lead, iron, mercury and zinc and the risk of Parkinson's disease
71. Parkinson's disease and occupational exposure to organic solvents, agricultural chemical and mercury - A case-referent study
72. A family history of Parkinson's disease and its effect on other PD risk factors
73. High prevalence of parkinsonism after occupational exposure to lead-sulfate batteries
74. Long term exposure to manganese in rural well water has no neurological effects
75. Dietary factors in Parkinson's disease: The role of food groups and specific foods
76. Dietary lipids and antioxidants in Parkinson's disease: A population-based, case-control study
77. A population-based case-control study of nutrient intake in Parkinson's disease
78. Dietary iron, animal fats, and risk of Parkinson's disease
79. Adult nutrient intake as a risk factor for Parkinson's disease
80. Diet and Parkinson's disease II: A possible role for the past intake of specific nutrients. Results from a self-administered food-frequency questionnaire in a case-control study
81. Case-control study of early life dietary factors in Parkinson's disease
82. Case-control study of idiopathic Parkinson's disease and dietary vitamin E intake
83. Diet and Parkinson's disease I: A possible role for the past intake of specific foods and food group. Results from a self-administered food-frequency questionnaire in a case-control study
84. Association of coffee and caffeine intake with the risk of Parkinson disease
85. Smoking, alcohol, and coffee consumption preceding Parkinson's disease: A case-control study
86. Vitamin use and Parkinson's disease (Abstract)
87. Antioxidant intake and risk of Parkinson's disease (PD) in older women
88. Serum levels of alpha-tocopherol (vitamin E) in Parkinson's disease
89. Plasma levels of vitamin E in Parkinson's disease
90. Alpha-tocopherol levels in brain are not altered in Parkinson's disease
91. Reduced and oxidized forms of glutathione and alpha-tocopherol in the cerebrospinal fluid of parkinsonian patients: Comparison between before and after L-Dopa treatment
92. Alpha-tocopherol in the ventricular cerebrospinal fluid of Parkinson's disease patients:dose-response study and correlations with plasma levels
93. Serum levels of beta-carotene and other carotenoids in Parkinson's disease
94. Overview of nutritional epidemiology
95. Memory of food intake in the distant past
96. Paralysis agitans and trauma
97. Parkinsonism due to various specific causes
98. Prior history of head trauma in Parkinson's disease
99. Head trauma as a risk factor for Parkinson's disease
100. Environmental factors in the etiology of Parkinson's disease
101. Incidence and risk factors of Parkinson's disease in The Netherlands
102. Magnetic resonance spectroscopic study of parkinsonism related to boxing
103. Trauma and movement disorders
104. Peripherally induced tremor and parkinsonism
105. 1918 Influenza, encephalitis lethargica, parkinsonism
106. Parkinsonism before and since the epidemic of encephalitis lathargica
107. Infection in childhood and neurological diseases in adult life
108. Levodopa therapy improves motor function in HIV-infected children with extrapyramidal syndrome
109. Diagnosis and immediate prognosis of Japanese B encephalitis
110. Japanese encephalitis and parkinsonism
111. Parkinsonism due to predominant involvement of substantia nigra in Japanese encephalitis
112. Para-encephalitic parkinsonism
113. Sequential parkinsonism and chorea following mild inluenza
114. Acute parkinsonism in suspected herpes simplex encephalitis
115. Encephalitis lethargica-like illness in a five-year-old
116. Basal ganglia calcification after mumps encephalitis
117. The substantia nigra is a major target for neurovirulent influenza A virus
118. Could Parkinson's disease follow intrauterine influenza? A speculative hypothesis
119. Does idiopathic parkinsonism in Aberdeen follow intrauterine influenza?
120. Measles infection and Parkinson's disease
121. Parkinson's disease and the environment in early life
122. Occupational risk factors in Parkinson's disease
123. Influenza viruses induce auto-antibodies to a brain-specific 37KDa protein in rabbit
124. Influenza virus antibodies in parkinsonism
125. The viral hypothesis in Parkinson's disease and Alzheimer's disease: A critique
126. A case-control study on the environmental risk factors of Parkinson's disease in Tianjin, China
127. Nocardia species as an etiologic agent in Parkinson's disease: Serological testing in a case-control study
128. Invasion of brain by neurovirulent influenza A virus after intranasal inoculation
129. Viral etiology for Parkinson's disease - A possible role of influenza A virus infection
130. The mortality of smokers and non-smokers
131. Tobacco consumption and mortality from cancer and other diseases
132. Cigarette smoking and protection from Parkinson's disease: False association or etiologic clue?
133. Smoking and Parkinson's disease
134. Smoking and Parkinson's disease. An age-dependent risk effect? The EUROPARKINSON Study Group
135. A new concept of Parkinson's disease as a complication of the cerebellar thoracic outlet syndrome
136. A genetic polymorphism of MAO-B modifies the association of cigarette smoking and Parkinson's disease
137. Smoking and Parkinson's disease: A dose-response relationship
138. Prospective study of cigarette smoking and the risk of developing idiopathic Parkinson's disease
139. Smoking-associated protection from Alzheimer's and Parkinson's disease
140. Evidence against the operation of selective mortality in explaining the association between cigarette smoking and reduced occurrence of idiopathic Parkinson's disease
141. Smoking and Parkinson's disease: A case-control study in Germany
142. Differential effects of acute and chronic nicotine treatment on MPTP-(1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) induced degeneration of nigrostriatal dopamine neurons in the black mouse
143. Basic and clinical psychopharmacology of nicotine
144. Effects of chronic nicotine infusion on tolerance development and nicotinic receptors
145. Cigarette smoking and Parkinson's disease
146. Nicotinic receptors and Parkinson's disease
147. The effects of nicotine on Parkinson's disease